Home › Therapeutic areas › Metabolic › Obesity

Obesity (13 companies)

Companies with an active program in Obesity.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
BMEA Biomea Fusion MetabolicOncology 2 Phase 2 $35.5M 4
ENTX Entera Bio GI/HepatologyMetabolic Rare 1 Phase 2 $522M 4
GUTS Fractyl Health Metabolic 1 Phase 3 $12.8M 1
MBX MBX Biosciences Metabolic Rare 3 Phase 3 $2.64B 4
MGTX MeiraGTx ImmunologyMetabolic+2 Rare 1 Phase 3 $827M 16
PTN Palatin Technologies ImmunologyMetabolic+1 1 Phase 3 $9.5M 5
PYPD PolyPid Infectious DiseaseMetabolic+1 1 NDA Submitted $138M 4
PTGX Protagonist Therapeutics DermatologyHematology+2 Rare 3 Approved $8.14B 12
RVPH Reviva Pharmaceuticals CardiovascularDermatology+3 Rare 1 Phase 3 $4.7M 11
RYTM Rhythm Pharmaceuticals Metabolic Rare 10 Approved $8.08B 14
GPCR Structure Therapeutics MetabolicRespiratory Rare 3 Phase 3 $3.90B 5
VKTX Viking Therapeutics MetabolicNeurology Rare 3 Phase 3 $3.43B 9
WVE Wave Life Sciences MetabolicNeurology+1 Rare 1 Phase 2 $560M 5